TP73 and endometrial cancer: These results suggest a mechanism through which SETD8 overexpression in endometrial cancer promotes the development of cancer by suppressing the expression of TP73 via H4K20 methylation and p53 methylation, thus inhibiting apoptosis (Figure 6E).